Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
SIGI
Selective Insurance
$83.51
Login to see Selective Insurance (SIGI) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Chart
$78.67 (+6.15%)
$87.55 (-4.61%)
$86.75 (-3.73%)
$98.68 (-15.37%)
SIGI has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Investors losing confidence
SIGI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
SIGI Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SIGI Street view is bullish but have mixed views on the near-term outlook
Average key support and resistance price levels.
Login to displaySIGI Earnings
The TTM reflects 12-month period, providing review of SIGI financial performance.
The company financial health has deteriorated over the past year
Financial Score
What is SIGI current stock price?
What are SIGI stock strengths?
What risks are associated with SIGI stock?
When is SIGI next earnings report?
What is SIGI market cap and volume?
What is SIGI's current Stock IQ?
Should I buy SIGI stock right now?
Is SIGI a Strong Buy right now?
What does a 'Strong Buy' rating mean for SIGI?
What does a 'Strong Sell' rating mean for SIGI?
What factors influence SIGI's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
SIGI
Selective Insurance
Current Price
$83.51
Stock Insights
Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Login to unlock Selective Insurance (SIGI) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$78.67 (+6.15%)
$87.55 (-4.61%)
$86.75 (-3.73%)
$98.68 (-15.37%)
SIGI Analysts Opinion
SIGI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
SIGI Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
SIGI Street view is bullish but have mixed views on the near-term outlook
SIGI has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Investors losing confidence
Average key support and resistance price levels.
Login to displaySIGI Earnings
The TTM data reflects the most recent 12-month period, providing overview of SIGI financial performance.
SIGI Financial Health
The company financial health has deteriorated over the past year
Financial Score
SIGI Latest Analysis
Selective sector bets key as markets ride policy and growth tailwinds . Chakri Lokapriya sees opportunities in infrastructure equipment makers defence plays like BEL and HAL and NBFCs benefiting from GST cuts gold prices and transport demand. He advises staying cautious on life insurers despite GST-driven volume growth citing pricing pressure and intense competition.
Tue Sep 23, 2025
Aquatech Acquires Kochs Direct Lithium Extraction Business Integrating Li-Pro™ DLE into the PEARL™ Technology Platform. CANONSBURG Pa. Sept. 16 2025 /PRNewswire/ -- Aquatech has acquired Koch Technology Solutions (KTS) direct lithium extraction (DLE) business integrating the Li-Pro™ Lithium Selective Sorption (LSS) technology and extensive Li-Pro IP portfolio into the PEARL™ process technology...
Tue Sep 16, 2025
Reunion Neuroscience Announces Final Closing of its Series A Financing and Plans to Advance RE104 into Clinical Development for the Treatment of Generalized Anxiety Disorder (GAD). -- Upsized Series A Financing Brings Total Amount Raised to $133 Million ---- GAD Affects 3.1% of United States Adult Population. Minority of Patients Receive Treatment ---- Reunion Expects to Initiate RECLAIM Phase 2 Trial Evaluating RE104 for GAD in 1Q 2026 --MORRISTOWN N.J. Sept. 16 2025 (GLOBE NEWSWIRE) -- Reunion
Tue Sep 16, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SIGI Stock trends
SIGI Stock performance
SIGI Stock analysis
SIGI investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings